IDEXX Laboratories Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.8% | 27.7% | 20.6% | 24.7% | 22.6% | 27.5% | 23.8% | 16.7% | 36.4% | 32.3% | 23.3% | 28.5% | 30.0% | |
| 3.2% | 3.3% | 3.1% | 3.2% | 3.5% | 3.5% | 3.4% | 6.3% | 3.3% | 3.6% | 3.3% | 3.4% | 3.4% | |
| 1.7% | 1.7% | 1.5% | 1.6% | 1.6% | 1.5% | 1.5% | 2.7% | -4.0% | 1.5% | 1.4% | 1.4% | 0.1% | |
| 1.8% | 4.6% | -8.4% | 1.4% | -5.9% | -0.9% | -6.1% | -14.8% | 20.3% | 1.6% | -7.9% | -4.7% | 2.1% | |
| 3.7% | 3.6% | 3.1% | 3.3% | 2.9% | 4.1% | 3.0% | 3.1% | 2.8% | 2.7% | 2.8% | 2.0% | 2.6% | |
| -3.0% | -3.4% | -11.1% | -3.3% | -2.8% | -4.2% | -3.0% | -3.0% | -4.1% | -2.6% | -2.9% | -2.1% | -2.9% | |
| 0.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -3.8% | -4.1% | -16.1% | -21.5% | -22.6% | -25.8% | -40.2% | -30.5% | -21.7% | -21.8% | -30.8% | -28.5% | -25.8% | |
| – | – | – | – | -7.7% | 0.0% | 7.0% | 14.1% | -11.2% | -12.1% | 11.6% | -0.9% | -3.0% | |
| -4.7% | -11.3% | -14.9% | -20.9% | -29.8% | -24.4% | -33.1% | -14.9% | -28.3% | -32.3% | -18.5% | -26.7% | -26.4% | |
| 21.7% | 13.6% | -5.9% | 0.4% | -9.5% | -2.1% | -12.4% | 0.1% | 3.9% | -2.6% | 1.8% | -0.3% | 0.7% | |
| 26.0% | 24.1% | 17.5% | 21.4% | 19.7% | 23.3% | 20.8% | 13.7% | 33.6% | 29.6% | 20.5% | 26.5% | 27.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.